Search the Newsreel

PMVP: Net loss narrowed, but liquidity concerns persist as rezatapopt advances toward NDA submission

PMV Pharmaceuticals (PMVP) reported a narrowed net loss of $18.1 million for Q2 2026, with $79.4 million in cash and equivalents. Despite progress with rezatapopt towards an NDA submission in early 2027, the company faces substantial doubt about its ability to continue operations without …

PMV Pharmaceuticals (PMVP) flags going-concern risk as rezatapopt advances toward NDA

PMV Pharmaceuticals reported a Q2 2026 net loss of $18.1 million and a first-half loss of $36.1 million, disclosing substantial doubt about its ability to continue as a going concern, as current cash resources are only expected to fund operations through Q2 2027. Despite …

Form 8K Pmv Pharmaceuticals Inc For: 14 August By Investing.com

This article from Investing.com announces the filing of a Form 8K by PMV Pharmaceuticals Inc. on August 14th. The brief piece includes the company's stock symbol PMVP and its real-time performance. The core content is minimal, serving primarily as a notification of the regulatory …

PMV Pharmaceuticals Inc (PMVP) Earnings Forecast: Future EPS & Revenue Growth Estimates

PMV Pharmaceuticals Inc (PMVP) Stock News Today

The article provides a snapshot of PMV Pharmaceuticals Inc (PMVP) stock information, including its current price, market capitalization, and a general overview. It indicates that more news regarding PMVP stock, earnings, analyst ratings, and key developments will be available soon.

PMVP Q2'26 Earnings: EPS estimate is (0.39) USD

PMV Pharmaceuticals, Inc. (PMVP) is expected to announce its Q2'26 financial results on August 6th, with the earnings call anticipated at 8:00 AM ET. Analysts project a revenue of $0 and an EPS of ($0.39) for the quarter. The article provides a table comparing …

Eversept Partners LP Invests $2.91 Million in PMV Pharmaceuticals, Inc. $PMVP

Eversept Partners LP has invested $2.91 million in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) by acquiring 2.35 million shares, representing a 4.40% stake in the company. Other institutional investors have also adjusted their holdings. PMV Pharmaceuticals recently reported a quarterly loss of $0.34 per share, beating …

Sio Capital discloses 4.94% PMV Pharmaceuticals (PMVP) stake below 5% threshold

Sio Capital Management, LLC has reported a beneficial ownership of 2,634,137 shares, or 4.94%, of PMV Pharmaceuticals (PMVP) common stock as of June 30, 2026. This stake is held by various client funds for which Sio acts as an investment adviser, with shared voting …

PMV Pharmaceuticals Inc (PMVP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey attempts to provide a revenue breakdown for PMV Pharmaceuticals Inc (PMVP), including business segments, regional revenue, and profit contributions. However, the core information indicates that these relevant data have not been disclosed by the company. The article therefore primarily highlights …

PMV Pharmaceuticals Inc (PMVP) Cash Flow

This article provides an in-depth look at the cash flow statement of PMV Pharmaceuticals Inc (PMVP), including operating, investing, and financing cash flows across various fiscal quarters and years. It details quarterly and annual cash flow figures, along with year-over-year percentage changes, and explains …

PMV Pharmaceuticals Inc (PMVP) Institutional Confidence

This article provides details on the institutional confidence in PMV Pharmaceuticals Inc (PMVP) by listing major institutional shareholders and their shareholdings. Key institutions include BML Capital Management LLC and Tang Capital Management, LLC, with some showing changes in their positions. The article also provides …

PMVP|PMV Pharmaceuticals Inc|Price:1.240|Chg%:-0.090

This article provides a detailed financial overview of PMV Pharmaceuticals Inc (PMVP), including its stock price, market capitalization, and various financial statements. It highlights key financial indicators such as EPS, net profit, current assets, total assets, total liabilities, and total equity across multiple quarters …

PMV Pharmaceuticals Inc (PMVP) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of PMV Pharmaceuticals Inc (PMVP), focusing on support, resistance, indicators, and moving averages. It includes a summary of various technical indicators like MACD, RSI, and STOCH, along with data on moving averages to offer a general trading signal. …

PMV Pharmaceuticals Inc (PMVP) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of PMV Pharmaceuticals Inc (PMVP) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years. The current stock price, market cap, and recent performance are also presented.